RecruitingNot ApplicableNCT06359886

B-lynch Transverse Compression Suture

B-lynch Transverse Compression Suture in the Prophylaxis and Control of Postpartum Heamorrhage in Patients With Placenta Previa: A Pilot Study


Sponsor

Alexandria University

Enrollment

25 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Is B-Lynch transverse compression suture safe and effective in controlling excessive blood loss during conservative management of women with placenta previa?


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria3

  • Single gestation
  • Elective CS for placenta preiva (diagnosed by transvaginal ultrasound).
  • Muliparity (para 2 or more).

Exclusion Criteria14

  • Morbidly adherent placenta: accrete, increta or percreta, diagnosed by abdominal and/or transvaginal ultrasound.
  • Ultrasonographic features of morbidly adherent placentas:
  • Loss of Retro-placental sonolucent zone.
  • Vascular lacunae.
  • Myometrial thinning.
  • Interruption of the bladder border.
  • More than 3 previous C.S.
  • Severely haemodynamic instablility needing immediate hysterectomy.
  • Patients with the cardiac, hepatic, renal or thromboembolic disease
  • Patients with coagulopathy:
  • Receiving anticoagulant therapy.
  • With thrombocytopenia or thrombasthenia.
  • Known coagulation factor defect.
  • Distorted uterus as unicornuate, bicornuate, fibroid uterus and adenomyosis uteri.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREB-Lynch Transverse Compression Suture

closure of uterine and utero ovarian arteries bilaterally with one suture


Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06359886


Related Trials